QIAGEN Benelux

QIAGEN NV, a Netherlands-based holding company, is the leading global provider of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. Our sample technologies isolate and process DNA, RNA and proteins from blood, tissue and other materials. Assay technologies make these biomolecules visible and ready for analysis. Bioinformatics software and knowledge bases interpret data to report relevant, actionable insights. Automation solutions tie these together in seamless and cost-effective workflows. QIAGEN provides solutions to more than 500,000 customers around the world in Molecular Diagnostics (human healthcare), Applied Testing (forensics, veterinary testing and food safety), Pharma (pharma and biotech companies) and Academia (life sciences research). As of September 30, 2018, QIAGEN employed approximately 4,900 people in over 35 locations worldwide.

Our broad product portfolio encompasses consumable kits, instruments, and bioinformatics that allow our customers to unlock insights from these molecules and address molecular testing challenges from Sample to Insight technologies. Discover more at www.qiagen.com/about-us/our-products.

Our new innovative instruments

Digital PCR (dPCR)

This innovative method is a highly precise approach to analytically sensitive and reproducible nucleic acid detection and quantification. Making digital PCR both scalable and practical, while reducing the time to scientific insight by integrating the qPCR workflow into a superior all-in-one walkaway solution, are the core drivers behind the development of the QIAcuity digital PCR platform. [more]